Equine Atopic Disease Symptomatic Therapy and Allergen-Specific Immunotherapy

Wayne Rosenkrantz, Stephen D White

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Scopus citations

Abstract

Equine atopic skin disease is typically considered a lifelong disease that requires chronic management. Management strategies include allergen avoidance, topical therapy, systemic medications, such as antihistamines, glucocorticoids, and tricyclic antidepressants, or a combination of all of these. Some of these options have undesirable adverse effects and limitations on usage in competition sporting events and avoidance of allergens is often impractical. Allergen-specific immunotherapy (ASIT) is therefore a practical option for many cases. There are a variety of different topical repellents and insecticides available to use to control insect allergens. As seen in other species with atopic dermatitis, topical therapy in the horse can provide emollient, moisturizing, and antipruritic effects and may improve epidermal barrier function.

Original languageEnglish (US)
Title of host publicationVeterinary Allergy
PublisherWiley Blackwell
Pages360-370
Number of pages11
ISBN (Electronic)9781118738818
ISBN (Print)9780470672419
DOIs
StatePublished - Jan 1 2013

Keywords

  • Allergen-specific immunotherapy (ASIT)
  • Antihistamines
  • Equine atopic disease
  • Glucocorticoids
  • Insect control
  • Mould control
  • Symptomatic therapy
  • Systemic therapy
  • Topical therapy

ASJC Scopus subject areas

  • veterinary(all)

Fingerprint Dive into the research topics of 'Equine Atopic Disease Symptomatic Therapy and Allergen-Specific Immunotherapy'. Together they form a unique fingerprint.

  • Cite this